The Future of Science Shouldn’t Come at the Cost of Dogs’ Lives
Imagine being a dog bred for the sole purpose of undergoing months of laboratory testing, only to be killed so researchers can examine your organs.
For countless beings in laboratories, this is reality. But one pharmaceutical company is challenging whether these practices are always necessary.
Vanda Pharmaceuticals is taking the FDA to court over requirements for additional animal toxicity testing.
At the heart of the dispute is a nine-month toxicity study involving dogs. Vanda argues that alternative, non-animal testing methods can provide important safety information and that the FDA has not adequately justified requiring additional animal studies before allowing its proposed long-term human clinical trial.
The FDA, however, maintains that the alternative studies submitted do not sufficiently establish the drug’s long-term safety.
This case raises an important question: If science is advancing, why are dogs still paying the price for outdated testing practices?
The FDA Modernization Act 2.0 opened the door to alternative testing methods, but legislation alone isn’t enough. We need continued advocacy, accountability, and investment in a future where animals are no longer subjected to unnecessary suffering in laboratories.
At Honey Paws, we’re fighting to make that future possible. Through education, advocacy, and direct action, we’re working to end animal testing and protect the lives of dogs who cannot speak for themselves.
We need your help to keep fighting.
Your donation allows Honey Paws to continue raising awareness, supporting advocacy campaigns, and pushing for a future where scientific progress doesn’t come at the expense of dogs’ lives.
Donate to Honey Paws today. Together, we can help change the future of science and give dogs the lives they deserve.
